Form 4: Envoy Medical CEO Increases Stake Through Employee Stock Purchase Plan

Envoy Medical, Inc. CEO and Director Brent T. Lucas has reported the acquisition of additional Class A Common Stock through the company's Employee Stock Purchase Plan, increasing his direct beneficial ownership.

Summary

• Brent T. Lucas, Chief Executive Officer and Director of Envoy Medical, Inc. (COCH), reported changes in his beneficial ownership of company securities.
• On November 30, 2024, Mr. Lucas acquired 5,165 shares of Class A Common Stock at a price of $1.94 per share.
• On May 30, 2025, he acquired an additional 7,742 shares of Class A Common Stock at a price of $1.2927 per share.
• Both acquisitions were made under the Envoy Medical, Inc. Employee Stock Purchase Plan and are exempt under SEC Rules 16b-3(d) and 16b-3(c).
• Following these transactions, Mr. Lucas directly beneficially owns 216,485 shares of Class A Common Stock.
• He also holds 879,749 stock options with an exercise price of $2.4, expiring on October 15, 2033, with a portion already vested and the remainder vesting pro rata monthly.
• Additionally, Mr. Lucas holds 110,987 warrants (94,293 and 16,694) with an exercise price of $11.5, expiring on September 29, 2028, all of which are fully exercisable.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While the transactions are routine ESPP acquisitions, they represent an increase in direct beneficial ownership by the CEO, which generally signals confidence and aligns management interests with shareholders. There are no negative disclosures.

Positives

• The CEO's participation in the Employee Stock Purchase Plan demonstrates continued confidence in the company's future and aligns management interests with those of shareholders.
• Increased direct beneficial ownership by a key executive can be viewed positively by investors as it signals commitment.

Future Outlook

The document primarily reports past and future scheduled insider transactions and does not provide a general future outlook or guidance for the company's operations or financial performance.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, specifically the acquisition of shares by a key executive through an Employee Stock Purchase Plan. It does not provide broader industry context or trends, but such transactions are common across all industries as part of executive compensation and incentive programs.

Stakeholder Impact

• Shareholders: The increased stake by the CEO through an ESPP can be seen as a positive signal of management's alignment with shareholder interests and confidence in the company's long-term prospects.
• Employees: The Employee Stock Purchase Plan allows employees, including executives, to acquire company stock, fostering a sense of ownership and aligning their financial interests with company performance.

Next Steps

• Continued pro rata vesting of the remaining 219,938 stock options on the 15th of each month for 36 consecutive months.

Key Dates

Keywords

Envoy Medical, COCH, Form 4, Insider Transaction, Brent T. Lucas, Employee Stock Purchase Plan, Stock Acquisition, CEO, Director, Beneficial Ownership, Stock Options, Warrants